Gave excellent returns to long-term investors

Long-term investment in the stock market always proves to be beneficial, especially when the investment is made in good companies. Sudarshan Pharma Industries is a great example of this. The company has given excellent returns to investors in recent years.

Investors’ stake increased after share distribution

• November 2024: Sudarshan Pharma split its shares.
• Face value: Earlier it was Rs 10, which reduced to Rs 1 per share.
• On Friday, January 10, 2025, the company’s shares fell by 2%.

Journey from IPO till now

• IPO launch:
  The company’s IPO was launched on 9 March 2023.
  • Lot Size: 1600 shares.
  • Minimum investment: Rs 1,16,800.
• After share split:
  Investors now hold a total of 16,000 shares.
• Current share price (10 January 2025):
  Rs 48.80 per share on BSE.
• Return:
  The investment of Rs 1.16 lakh has increased to Rs 7.80 lakh in about 2 years.
  • That means investors have got 7 times return.

Company performance and market cap

• 52 Week High: Rs 53.50.
• 52 Week Low: Rs 5.82.
• Market Cap: Rs 1174.42 crore.

Sudarshan Pharma business

Sudarshan Pharma provides various services to the pharma and chemical industry.

• Export Market:
  The company exports its products to countries like UK, Australia, Uzbekistan, Syria, Oman, Taiwan.
• Services:
  • Contract Manufacturing.
  • Outsourcing.
  • Supply of generic formulations and medicines.

According to the company’s website, it is known for innovative solutions and quality products.